Capstan Therapeutics

Developer of gene therapies intended to treat rare genetic diseases. The company's pipeline includes treatments for genetic disorders affecting the central nervous system and muscle, and uses a proprietary adeno-associated virus (AAV) technology, allowing for targeted gene delivery.